High-throughput RNAi screening for N-glycosylation dependent loci in caenorhabditis elegans

Methods in Enzymology

Volumn 480, Issue C, 2010, Pages 477-493

  Struwe, Weston B ^a   Warren, Charles E ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; RNA; TUNICAMYCIN;

ARTICLE; CAENORHABDITIS ELEGANS; DOSE RESPONSE; EUKARYOTE; GENE LOCUS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOME; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE;

CAENORHABDITIS ELEGANS; EUKARYOTA; METAZOA;

EID: 77956148431     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)80021-7     Document Type: Chapter

References (27)

1. Aebi M., Hennet T. Congenital disorders of glycosylation: Genetic model systems lead the way. Trends Cell Biol. 2001, 11(3):136-141.
2. Altmann F., Fabini G., Ahorn H., Wilson I.B. Genetic model organisms in the study of N-glycans. Biochimie 2001, 83(8):703-712.
3. Asikainen S., Vartiainen S., Lakso M., Nass R., Wong G. Selective sensitivity of Caenorhabditis elegans neurons to RNA interference. Neuroreport 2005, 16(18):1995-1999.
4. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77(1):71-94.
5. C. elegans Sequencing Consortium Genome sequence of the nematode C. elegans: A platform for investigating biology. Science 1998, 282(5396):2012-2018.
6. Chen S., Zhou S., Sarkar M., Spence A.M., Schachter H. Expression of three Caenorhabditis elegans N-acetylglucosaminyltransferase I genes during development. J. Biol. Chem. 1999, 274(1):288-297.
7. Chen S., Tan J., Reinhold V.N., Spence A.M., Schachter H. UDP-N-acetylglucosamine:alpha-3-d-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-6-d-mannoside beta-1,2-N-acetylglucosaminyltransferase II in Caenorhabditis elegans. Biochim. Biophys. Acta 2002, 1573(3):271-279.
8. Cipollo J.F., Costello C.E., Hirschberg C.B. The fine structure of Caenorhabditis elegans N-glycans. J. Biol. Chem. 2002, 277(51):49143-49157.
9. Cipollo J.F., Awad A., Costello C.E., Robbins P.W., Hirschberg C.B. Biosynthesis in vitro of Caenorhabditis elegans phosphorylcholine oligosaccharides. Proc. Natl. Acad. Sci. USA 2004, 101(10):3404-3408.
10. Cipollo J.F., Awad A.M., Costello C.E., Hirschberg C.B. N-Glycans of Caenorhabditis elegans are specific to developmental stages. J. Biol. Chem. 2005, 280(28):26063-26072.
11. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391(6669):806-811.
12. Hanneman A.J., Rosa J.C., Ashline D., Reinhold V.N. Isomer and glycomer complexities of core GlcNAcs in Caenorhabditis elegans. Glycobiology 2006, 16(9):874-890.
13. Haslam S.M., Dell A. Hallmarks of Caenorhabditis elegans N-glycosylation: Complexity and controversy. Biochimie 2003, 85(1-2):25-32.
14. Hope I.A. C. elegans: A practical approach. 1999, Oxford University Press, Oxford, New York.
15. Huffaker T.C., Robbins P.W. Temperature-sensitive yeast mutants deficient in asparagine-linked glycosylation. J. Biol. Chem. 1982, 257(6):3203-3210.
16. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperlen P., et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003, 421(6920):231-237.
17. Lambie E.J. Cell proliferation and growth in C. elegans. Bioessays 2002, 24(1):38-53.
18. Lehle L., Strahl S., Tanner W. Protein glycosylation, conserved from yeast to man: A model organism helps elucidate congenital human diseases. Angew. Chem. Int. Ed. Engl. 2006, 45(41):6802-6818.
19. Natsuka S., Adachi J., Kawaguchi M., Nakakita S., Hase S., Ichikawa A., Ikura K. Structural analysis of N-linked glycans in Caenorhabditis elegans. J. Biochem. 2002, 131(6):807-813.
20. Paschinger K., Gutternigg M., Rendic D., Wilson I.B. The N-glycosylation pattern of Caenorhabditis elegans. Carbohydr. Res. 2008, 343(12):2041-2049.
21. Prietsch V., Peters V., Hackler R., Jakobi R., Assmann B., Fang J., Korner C., Helwig-Rolig A., Schaefer J.R., Hoffmann G.F. A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. J. Inherit. Metab. Dis. 2002, 25(2):126-130.
22. Rual J.F., Ceron J., Koreth J., Hao T., Nicot A.S., Hirozane-Kishikawa T., Vandenhaute J., Orkin S.H., Hill D.E., van den Heuvel S., Vidal M. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res. 2004, 14(10B):2162-2168.
23. Schachter H. Protein glycosylation lessons from Caenorhabditis elegans. Curr. Opin. Struct. Biol. 2004, 14(5):607-616.
24. Schollen E., Kjaergaard S., Martinsson T., Vuillaumier-Barrot S., Dunoe M., Keldermans L., Seta N., Matthijs G. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion. J. Med. Genet. 2004, 41(11):877-880.
25. Simmer F., Moorman C., van der Linden A.M., Kuijk E., van den Berghe P.V., Kamath R.S., Fraser A.G., Ahringer J., Plasterk R.H. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 2003, 1(1):E12.
26. Struwe W.B., Hughes B.L., Osborn D.W., Boudreau E.D., Shaw K.M., Warren C.E. Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci. Glycobiology 2009, 19(12):1554-1562.
27. Warren C.E., Krizus A., Roy P.J., Culotti J.G., Dennis J.W. The Caenorhabditis elegans gene, gly-2, can rescue the N-acetylglucosaminyltransferase V mutation of Lec4 cells. J. Biol. Chem. 2002, 277(25):22829-22838.